UNSPSC 51162722: Moguisteine

Commodity

Code facts

NIGP codes
1

UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.

NIGP codes for 51162722

Definition

This classification denotes a mucolytic agent with the molecular formula C16H21NO5S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 6Y556547YY, chemically known as 3-thiazolidinepropanoic acid, 2-((2-methoxyphenoxy)methyl)-beta-oxo-, ethyl ester, (+-)- but more generally known as moguisteine, which bears US NIH Compound Identifier 65935. European Medicines Agency schedules Moguisteine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09038MIG.

Read the full definition

The term MOGUISTEINE is an International Non-Proprietary Name. Most nations, for tariff and trade purposes, schedule moguisteine under HS 29341000 and SITC 51579. As of Q4 2014, MOGUISTEINE remains US FDA's Preferred Term for this commodity. Moguisteine bears US NLM identifiers UMLS ID C0256172 and NCI Concept Code C66178. SMILES: S1C(N(CC1)C(=O)CC(=O)OCC)COC1C(OC)CCCC1.

About UNSPSC 51162722

UNSPSC 51162722 Moguisteine is a Commodity code under which state and local governments procure parenteral products, intravenous solutions, and pharmaceutical supplies for healthcare delivery in correctional and community health settings. The Washington State Department of Corrections issued RFQ RFQQK13020 in September 2026 to solicit parenteral nutrition solutions (TPN and PPN), IV solutions, and controlled substances for delivery to eight correctional facilities across the state, with responses due October 7, 2026. The scope includes documented experience preparing and delivering IV solutions with 24-hour turnaround for nutrition bags and 8-hour delivery for other parenteral products. State correctional and public health agencies are the primary issuing bodies under this code, with preferences for small businesses (25% goal), minority-owned businesses (10%), women-owned businesses (6%), and veteran-owned businesses (5%) where certified under state programs.

Recent activity spans Washington and Florida. The Washington State Department of Corrections RFQ anticipates awarding up to three contractors per region (West, Central, East) for an initial term through June 30, 2030, with fixed pricing for the first two years and mandatory insurance including $1 million commercial general liability and $2 million professional liability. A second opportunity from Seminole County, Florida (IFB 60459723LAS) sought 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building, though that solicitation's posted response date of July 26, 2023 has passed. The Washington solicitation requires Washington State business licensure and successful Washington State Patrol NCIC clearance for all service personnel, with pre-bid conference scheduled September 23, 2026 and questions due September 22, 2026.

Quick answers

What is UNSPSC 51162722?

UNSPSC 51162722 is Moguisteine, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.

Which NIGP codes match UNSPSC 51162722?

UNSPSC 51162722 maps to 1 NIGP code, 26948 Expectorants, Antitussives, and Mucolytic Agents.

On GovTribe

See everything under UNSPSC 51162722

  • State & local contract opportunities, awards and contract vehicles under this code
  • Contacts who buy under this code
  • Ask GovTribe AI about this code